75 %Aflatoxin B1 was detected in 6 of 8 women living with HIV with detectable HIV viral load (75.0%).
KenyaVIH/sidapublié 2025International journal of STD & AIDSPubMeddocument de 8 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
6 677 evidences · page 23 / 268
75 %Aflatoxin B1 was detected in 6 of 8 women living with HIV with detectable HIV viral load (75.0%).
KenyaVIH/sidapublié 2025International journal of STD & AIDSPubMeddocument de 8 observations
81 %HSV-2 prevalence was 81% among HIV-1 seronegative sex workers from Mombasa, Kenya.
Kenyaherpes simplex virus-2publié 2007AIDS (London, England)europe_pmcdocument de 6 observationsDOI 10.1097/qad.0b013e328270388a
9 %Meningitis or encephalitis was present in 15 (9%) of 162 HIV-attributed infant or child deaths.
Kenyameningitis or encephalitis · VIH/sidaobservé Dec 3, 2016 to Dec 31, 2024publié 2026The lancet. HIVPubMeddocument de 23 observations
3,4 yearsThe median estimated time since HIV infection (ETI) among adolescent girls and young women who self-identify as female sex workers in Mombasa, Kenya, was 3.4 years.
KenyaVIH/sidapublié 2023AIDS (London, England)PubMeddocument de 3 observations
99 %Uptake of cotrimoxazole prophylaxis among TB/HIV co-infected patients was 99%.
Kenyatuberculose · VIH/sidaobservé 2012–2020publié 2023BMC infectious diseasesPubMeddocument de 11 observations
380 US$ per year-of-life-savedPaclitaxel has an incremental cost-effectiveness ratio of US$380 per year-of-life-saved compared with bleomycin-vincristine for advanced AIDS-associated Kaposi sarcoma in Kenya.
Kenyaadvanced AIDS-associated Kaposi sarcomapublié 2022The Lancet. Global healthPubMeddocument de 5 observations
12 per_317Among 317 women, CIN1 cases included HPV81 in 12/317 (3.8%) and HPV11 in 2/317 (0.6%).
KenyaCIN1publié 2021BioMed research internationalPubMeddocument de 9 observations
16 %Among 67 transfeminine participants, eight (16%) reported current symptoms consistent with a rectal STI.
Kenyasexually transmitted infection (STI)observé 2017publié 2021The lancet. HIVPubMeddocument de 14 observations
27,1 %At 36 months, loss to follow-up among patients initiated on antiretroviral therapy in central Kenya was 27.1%.
KenyaVIH/sidaobservé 36 monthspublié 2022BMC infectious diseasesPubMeddocument de 10 observations
3 646 partnersFrom March to December 2021, 3646 partners were eligible for HIV testing.
KenyaVIH/sidaobservé March to December 2021publié 2024Journal of the International AIDS SocietyPubMeddocument de 15 observations
51,1 %Just over half of publications on adolescent sexual and reproductive health in sub-Saharan Africa had authors with African institutional affiliations as first authors (51.1%).
Kenyaadolescent sexual and reproductive healthpublié 2021BMJ global healthPubMeddocument de 12 observations
85 %Malaria testing services were available at more than 85% of facilities.
Kenyapaludismepublié 2022Malaria journaleurope_pmcdocument de 10 observationsDOI 10.1186/s12936-022-04048-2
57 %Among 731 HIV-negative participants in the Maisha Fiti cohort of women who sell sex in Nairobi, Kenya, 414 (57%) were HSV-2 seropositive.
KenyaHerpes simplex virus type 2publié 2026American journal of reproductive immunology (New York, N.Y. : 1989)PubMeddocument de 3 observations
Superinfected women had a trend for increased viral load at superinfection acquisition (P = 0.09).
KenyaVIH/sidapublié 2014AIDS (London, England)europe_pmcdocument de 6 observations
230 174 individualsPlasmodium falciparum prevalence data covered an examination of 230,174 individuals located in northern Namibia.
Kenyapaludismeobservé 1969–1992publié 2013PloS oneeurope_pmcdocument de 6 observations
5,4 per_1000The mean incidence of Plasmodium vivax in 2009 was 5.4 cases per 1000 population.
Kenyapaludismeobservé 2009publié 2014PloS oneeurope_pmcdocument de 7 observations
58 %Only 94 (58%) of 162 HIV-attributed cases had documented antemortem diagnoses.
KenyaVIH/sidaobservé Dec 3, 2016 to Dec 31, 2024publié 2026The lancet. HIVPubMeddocument de 23 observations
The introduction of insecticide-treated bed nets during a randomized controlled trial on the Kenyan coast significantly reduced severe, life-threatening malaria and all-cause childhood mortality.
Kenyapaludismepublié 1997Acta tropicaeurope_pmcdocument de 4 observations
2 %2% of the population in Kenya has diabetes mellitus.
Kenyadiabète (non précisé)publié 2021The Pan African medical journalPubMeddocument de 3 observations
23 %At baseline, 23.0% of older adults living with HIV in western Kenya were hypertensive.
Kenyahypertension artériellepublié 2026BMC cardiovascular disordersPubMeddocument de 6 observations
8,8 %Interventions that prevent future violence without mitigating the effects of past violence may prevent a median of 8.8% of HIV infections over 10 years in female sex workers and their clients in Mombasa, Kenya.
KenyaVIH/sidaobservé 10 yearspublié 2024BMC medicinePubMeddocument de 9 observations
8 %National malaria prevalence in Kenya was 8% in 2018.
Kenyapaludismeobservé 2018publié 2022Malaria journalPubMeddocument de 8 observations
3 foldMalaria prevalence is three-fold higher in western Kenya than the national average of 6%.
Kenyapaludismepublié 2023Malaria journalPubMeddocument de 8 observations
4 %Among adolescent girls and young women seeking contraceptive services at four public sector family planning clinics in Kisumu, Kenya, from October 2018 to June 2019, 4% initiated pre-exposure prophylaxis (PrEP) at their current family planning visit.
KenyaVIH/sidaobservé October 2018 to June 2019publié 2020AIDS patient care and STDsPubMeddocument de 10 observations
3 %Among adolescents living with HIV in Kenya, 3% reported no longer being able to get medication refills due to COVID-19.
KenyaCOVID-19publié 2021AIDS and behaviorPubMeddocument de 6 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.